Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 02 Mar 2023 for Albireo Pharma, INC.. Read the official filing
Filing timeline
BuySaleJan Mattsson
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jan Mattsson: trading record in brief
Jan Mattsson is a declared insider of Albireo Pharma, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 18 January 2022 and 2 March 2023, the trades on record add up to 10 filings.
Every open-market trade on record is a sale: 6 sales worth €166k. Other entries cover 3 share grants. In 2023 alone, the filings show no purchases and 2 sales.
On 2 March 2023 came the latest disclosure, a transaction in Albireo Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jan Mattsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
35,524 sharesCommon StockSEC:0001209191-23-014736:0
55,000 shares0Common StockSEC:0001209191-23-005337:0
55,000 shares0Common StockSEC:0001209191-23-004952:0
197 shares@ US$43.804.3% of flowCommon StockSEC:0001209191-23-004455:0
3,088 shares@ US$43.8068.2% of flowCommon StockSEC:0001209191-23-004222:0
202 shares@ US$19.57642.2% of flowCommon StockSEC:0001209191-22-054489:0
205 shares@ US$24.67522.7% of flowCommon StockSEC:0001209191-22-043112:0
200 shares@ US$32.92473.7% of flowCommon StockSEC:0001209191-22-025526:0
808 shares@ US$24.882210.7% of flowCommon StockSEC:0001209191-22-004803:0
21,600 shares0Common StockSEC:0001209191-22-004068:0
10 of 10 declarations
